HIV pre-exposure prophylaxis for women

HIV pre-exposure prophylaxis for women

Women and girls comprise nearly half of HIV-infected individuals globally and 20% of new infections in the United States, indicating an urgent need to optimise HIV prevention options in this population. HIV pre-exposure prophylaxis (PrEP) - where antiretrovirals are administered to HIV-non-infected individuals at risk of HIV acquisition - is a promising, female-controlled HIV prevention strateg...

Pre-exposure prophylaxis for HIV prevention in women: current perspectives

There are ~900,000 new HIV infections among women every year, representing nearly half of all new HIV infections globally. In the US, nearly one-fifth of all new HIV infections occur among women, and women from racial and ethnic minority communities experience disproportionately high rates of new HIV infections. Thus, there is a need to develop and implement effective HIV prevention strategies ...

Perspectives of women prescribed HIV pre-exposure prophylaxis (PrEP)

Pre-Exposure Prophylaxis for HIV Prevention.

c ase vignet tes The first patient, a 46-year-old sexually active man who has sex with men, presents for routine primary care. He lives in New York City and reports that he is in a long-term, stable, open relationship with a male partner and that he has had multiple recent sexual encounters with acquaintances. A recent HIV test was negative. He has seasonal allergies, for which he occasionally ...

Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis.

Although RCTs have not been conducted to establish the effıcacy of non-occupational postexposure prophylaxis (nPEP), studies in nonhuman primates have demonstrated protection with nPEP; observational data support the effıcacy of PEP for occupational exposures; and several studies have esablished the feasibility of nPEP delivery in various setings. Based on these data, the CDC and public health ...